Mon. 13 May 2024, 8:24am ET
Benzinga
Earnings, Earnings Beats, News
Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.69) by 24.64 percent. This is a 48.57 percent decrease over losses of $(0.35) per share from the same period last year.